Kezar Life Sciences
132 hedge funds and large institutions have $480M invested in Kezar Life Sciences in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 127 → 132 (+5)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.67% less ownership
Funds ownership: 9.09% → 8.42% (-0.67%)
Holders
132
Holding in Top 10
4
Calls
$9.9M
Puts
$1.95M
Top Buyers
| 1 | +$24.1M | |
| 2 | +$11.7M | |
| 3 | +$8.15M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$6.89M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$5.15M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$11.7M | |
| 3 | -$10.8M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.92M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$9.79M |